Published in Infect Immun on September 01, 1990
Exotoxins of Staphylococcus aureus. Clin Microbiol Rev (2000) 7.35
Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J Exp Med (1992) 2.38
Characterization and biological properties of a new staphylococcal exotoxin. J Exp Med (1994) 1.91
Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Infect Immun (1993) 1.33
Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents. Proc Natl Acad Sci U S A (1991) 1.22
Predictions of T-cell receptor- and major histocompatibility complex-binding sites on staphylococcal enterotoxin C1. Infect Immun (1994) 1.20
Localization of biologically important regions on toxic shock syndrome toxin 1. Infect Immun (1996) 1.19
Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1. J Exp Med (1995) 1.13
A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity. Infect Immun (1995) 0.99
Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model. Infect Immun (1995) 0.96
Mitogenic activities of amino acid substitution mutants of staphylococcal enterotoxin B in human and mouse lymphocyte cultures. Infect Immun (1996) 0.88
Delineation by use of specific monoclonal antibodies of the T-cell receptor and major histocompatibility complex interaction sites on the superantigen toxic shock syndrome toxin 1. Infect Immun (1996) 0.83
Role of a carboxy-terminal site of toxic shock syndrome toxin 1 in eliciting immune responses of human peripheral blood mononuclear cells. Infect Immun (1995) 0.81
Mutational analysis of superantigen activity responsible for the induction of skin erythema by streptococcal pyrogenic exotoxin C. Infect Immun (1998) 0.80
A toxic shock syndrome toxin 1 mutant that defines a functional site critical for T-cell activation. Infect Immun (1995) 0.79
The effect of site-specific monoclonal antibodies directed to toxic shock syndrome toxin-1 in experimental Staphylococcus aureus arthritis. Clin Exp Immunol (1999) 0.75
Localization of a T-cell epitope of superantigen toxic shock syndrome toxin 1 to residues 125 to 158. Infect Immun (1998) 0.75
Application of a Chimeric Protein Construct having Enterotoxin B and Toxic Shock Syndrome Toxin Domains of S. aureus in Immunodiagnostics. Indian J Microbiol (2012) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A (1985) 68.48
Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods (1984) 11.70
Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis (1981) 8.40
A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet (1981) 7.69
Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci U S A (1989) 7.48
The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell (1989) 7.02
High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature (1989) 3.99
Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet (1986) 2.69
The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1. J Biol Chem (1986) 2.63
Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon. J Exp Med (1988) 2.61
Induction of human interleukin-1 by toxic-shock-syndrome toxin-1. J Infect Dis (1985) 2.37
Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins. JAMA (1985) 2.16
A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1. Infect Immun (1987) 2.13
Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources. Infect Immun (1983) 2.08
Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome. J Infect Dis (1983) 2.08
Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain. J Biol Chem (1988) 1.73
Toxic-shock-syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes. J Infect Dis (1985) 1.65
Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo. Infect Immun (1988) 1.36
Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers. J Infect Dis (1984) 1.28
Analysis of the mitogenic effects of toxic shock toxin on human peripheral blood mononuclear cells in vitro. Clin Immunol Immunopathol (1984) 1.27
Needles that kill: modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. Rev Infect Dis (1989) 1.25
Localization of biologic functions of toxic shock syndrome toxin-1 by use of monoclonal antibodies and cyanogen bromide-generated toxin fragments. J Immunol (1986) 1.24
Toxic shock syndrome toxin-1 induces inositol phospholipid turnover, protein kinase C translocation, and calcium mobilization in human T cells. J Immunol (1988) 1.17
Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: immunosuppression by adherent spleen cells. Infect Immun (1985) 1.15
Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1. J Immunol (1990) 1.12
Protection of rabbits in an infection model of toxic shock syndrome (TSS) by a TSS toxin-1-specific monoclonal antibody. Infect Immun (1988) 0.96
Cloning and expression of streptococcal pyrogenic exotoxin A and staphylococcal toxic shock syndrome toxin-1 in Bacillus subtilis. Mol Gen Genet (1987) 0.94
Effect of chemical modification of histidine and tyrosine residues in toxic shock syndrome toxin 1 on the serologic and mitogenic activities of the toxin. Infect Immun (1989) 0.83
Rapid purification of staphylococcal enterotoxin B by high-pressure liquid chromatography. J Clin Microbiol (1989) 0.83
Localization of a biologically important epitope on toxic-shock-syndrome toxin-1. J Infect Dis (1988) 0.80
Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J Infect Dis (1982) 8.05
Shigella infection of Henle intestinal epithelial cells: role of the bacterium. Infect Immun (1979) 5.24
Shigella infection of henle intestinal epithelial cells: role of the host cell. Infect Immun (1979) 5.09
Inhibition of in vitro protein synthesis by Shigella dysenteriae 1 toxin. Biochem Biophys Res Commun (1976) 3.30
Biological properties of Shigella flexneri 2A toxin and its serological relationship to Shigella dysenteriae 1 toxin. Infect Immun (1977) 2.94
Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade. Cancer Res (2000) 2.89
The Department of Health's "two week standard" for bowel cancer: is it working? Gut (2004) 2.88
Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography. Infect Immun (1980) 2.82
Training in large bowel cancer surgery: observations from three prospective regional United Kingdom audits. BMJ (1999) 2.44
The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J Biol Chem (1992) 2.40
Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels. Ann Intern Med (1991) 2.29
Studies on the mode of action of diphtheria toxin. I. Protein synthesis in guinea pig tissues. J Exp Med (1966) 2.22
Indomethacin and perforated duodenal ulcer. Br Med J (1980) 2.21
Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources. Infect Immun (1983) 2.08
Production of exoenzyme S during Pseudomonas aeruginosa infections of burned mice. Infect Immun (1979) 1.86
Bascom's operation in the day-surgical management of symptomatic pilonidal sinus. Br J Surg (2000) 1.85
alpha beta T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases. Immunity (1996) 1.79
Anomalous high native resistance to athymic mice to bacterial pathogens. Infect Immun (1977) 1.75
Changes over time in socioeconomic inequalities in breast and rectal cancer survival in England and Wales during a 32-year period (1973-2004): the potential role of health care. Ann Oncol (2011) 1.72
Elimination of Leishmania donovani amastigotes by activated macrophages. Infect Immun (1981) 1.58
Phagocytosis and intracellular killing of Staphylococcus aureus by normal mouse peritoneal macrophages. Infect Immun (1975) 1.57
A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem (2000) 1.54
Hydrodynamic structure of bovine serum albumin determined by transient electric birefringence. Biophys J (1975) 1.52
Cleft closure for the treatment of pilonidal sinus disease. Colorectal Dis (2011) 1.52
Simple and reliable enzyme-linked immunosorbent assay with monoclonal antibodies for detection of Escherichia coli heat-stable enterotoxins. J Clin Microbiol (1984) 1.48
Enhanced metabolism of Leishmania donovani amastigotes at acid pH: an adaptation for intracellular growth. Science (1985) 1.48
Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis. Am J Med (1992) 1.46
Theory and application of static field inhomogeneity effects in gradient-echo imaging. J Magn Reson Imaging (1997) 1.40
Studies on the mode of action of diphtheria toxin. III. Effect on subcellular components of protein synthesis from the tissues of intoxicated guinea pigs and rats. J Exp Med (1970) 1.40
Chemical modulation of diphtheria toxin action on cultured mammalian cells. Infect Immun (1975) 1.37
Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo. Infect Immun (1988) 1.36
Receptor-mediated entry of diphtheria toxin into monkey kidney (Vero) cells: electron microscopic evaluation. Infect Immun (1985) 1.36
A role for oxygen-dependent mechanisms in killing of Leishmania donovani tissue forms by activated macrophages. J Immunol (1982) 1.36
Interaction of cultured mammalian cells with [125I] diphtheria toxin. Infect Immun (1975) 1.34
Lethal toxin of Bacillus cereus. I. Relationships and nature of toxin, hemolysin, and phospholipase. J Bacteriol (1967) 1.32
The epidemiology of genital colonization with Staphylococcus aureus. Ann Intern Med (1982) 1.32
Revised amino acid sequence for a heat-stable enterotoxin produced by an Escherichia coli strain (18D) that is pathogenic for humans. Infect Immun (1985) 1.32
The effect of neutral and acidic polysaccharides on natural resistance of mice to bacterial challenge. J Infect Dis (1965) 1.32
Evidence of the effect of 'specialization' on the management, surgical outcome and survival from colorectal cancer in Wessex. Br J Surg (2003) 1.32
Differential requirements for ZAP-70 in TCR signaling and T cell development. J Immunol (1998) 1.31
Studies on the mode of action of diphtheria toxin. II. Protein synthesis in primary heart cell cultures. J Exp Med (1967) 1.31
Rapid screening assay for toxic shock syndrome toxin production by Staphylococcus aureus. J Clin Microbiol (1984) 1.31
Citrobacter freundii produces an 18-amino-acid heat-stable enterotoxin identical to the 18-amino-acid Escherichia coli heat-stable enterotoxin (ST Ia). Infect Immun (1989) 1.31
The relation of respiration rate and heart rate to sleep states in the human newborn. Dev Med Child Neurol (1971) 1.30
Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers. J Infect Dis (1984) 1.28
Autoradiographic evidence for the impermeability of mouse peritoneal macrophages to tritiated streptomycin. J Bacteriol (1967) 1.27
Phagocytosis and intracellular disposition of viable bacteria by the isolated perfused rat liver. J Reticuloendothel Soc (1965) 1.26
In vitro production of an extracellular protease by Legionella pneumophila. Infect Immun (1981) 1.26
Status of bacterial toxins and their nomenclature: need for discipline and clarity of expression. Bacteriol Rev (1967) 1.23
Killing of intraphagocytic Staphylococcus aureus by dihydrostreptomycin entrapped within liposomes. Antimicrob Agents Chemother (1978) 1.20
Evaluation of Delorme's procedure as a treatment for full-thickness rectal prolapse. Br J Surg (2000) 1.16
High current-carrying capability in c-axis-oriented superconducting MgB2 thin films. Phys Rev Lett (2001) 1.16
Enhancement of carrier-mediated transport after immunologic activation of peritoneal macrophages. J Immunol (1977) 1.16
Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: immunosuppression by adherent spleen cells. Infect Immun (1985) 1.15
Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid. Am Rev Respir Dis (1992) 1.12
Biological and immunological characteristics of 125I-4Tyr and -18Tyr Escherichia coli heat-stable enterotoxin species purified by high-performance liquid chromatography. Anal Biochem (1985) 1.12
Synergistic induction of interleukin-1 by endotoxin and toxic shock syndrome toxin-1 using rat macrophages. Infect Immun (1987) 1.09
Facilitated uptake of streptomycin by Kupffer cells during phagocytosis. Nature (1967) 1.09
School breakfast improves verbal fluency in undernourished Jamaican children. J Nutr (1995) 1.07
Cell-mediated immune phenomena induced by lymphokines from splenic lymphocytes of mice with chronic staphylococcal infection. Infect Immun (1975) 1.07
Binding of E. coli heat-stable enterotoxin to rat intestinal brush borders and to basolateral membranes. Dig Dis Sci (1987) 1.07
Disease stage and psychosocial outcomes in colorectal cancer. Colorectal Dis (2008) 1.05
Inhibition of protein synthesis after intravenous or intramuscular challenge with diphtheria toxin. Infect Immun (1972) 1.05
Social deprivation and outcomes in colorectal cancer. Br J Surg (2006) 1.05
Shigellosis and Escherichia coli diarrhea: relative importance of invasive and toxigenic mechanisms. Am J Clin Nutr (1979) 1.05
MgB2 superconducting thin films with a transition temperature of 39 kelvin. Science (2001) 1.05
Locomotor activity in Drosophila. 3. A distinction between activity and reactivity. Anim Behav (1967) 1.04
Enhanced phagocytosis, killing, and serum sensitivity of Escherichia coli and Staphylococcus aureus treated with sub-MICs of imipenem. Antimicrob Agents Chemother (1988) 1.04
Comparison of circumferential margin involvement between restorative and nonrestorative resections for rectal cancer. Colorectal Dis (2005) 1.03
Efficacy of combined immunostimulation and chemotherapy in experimental visceral Leishmaniasis. Am J Trop Med Hyg (1983) 1.02
Developmental changes in associated movements. Dev Med Child Neurol (1968) 1.02
Blinded, two-laboratory comparative analysis of Escherichia coli heat-stable enterotoxin production by using monoclonal antibody enzyme-linked immunosorbent assay, radioimmunoassay, suckling mouse assay, and gene probes. J Clin Microbiol (1986) 1.02
The function and processing of auditory information in the courtship behaviour of Drosophila melanogaster. Anim Behav (1971) 1.02
Synthesis and proof of structure of the new amino acid in prothrombin. Biochem Biophys Res Commun (1975) 1.01
Learning and the concept of critical periods in infancy. Dev Med Child Neurol (1972) 1.00
Cultural, phagocytic, and bactericidal characteristics of peritoneal macrophages. J Reticuloendothel Soc (1973) 1.00
A single base mutation in an I-A alpha-chain gene alters T-cell recognition. Proc Natl Acad Sci U S A (1987) 0.99
Sexual isolation and courtship behavior in Drosophila simulans, D. mauritiana, and their interspecific hybrids. Behav Genet (1988) 0.99
Crystal structure of a biologically inactive mutant of toxic shock syndrome toxin-1 at 2.5 A resolution. Protein Sci (1996) 0.98
Locomotor activity in drosophila. II. Selection for active and inactive strains. Anim Behav (1966) 0.98
Gastric mucosal lesions produced by intravenous infusion of aspirin in cats. Gastroenterology (1976) 0.98
Evidence for pseudomonas exotoxin A receptors on plasma membrane of toxin-sensitive lm fibroblasts. Infect Immun (1984) 0.97
Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats. Am J Physiol Gastrointest Liver Physiol (2000) 0.96
Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model. Infect Immun (1995) 0.96
Hepatic inactivation of gastrins of various chain lengths in dogs. Gastroenterology (1978) 0.96
Protection of rabbits in an infection model of toxic shock syndrome (TSS) by a TSS toxin-1-specific monoclonal antibody. Infect Immun (1988) 0.96
Maternal thyroid function and motor competence in the child. Dev Med Child Neurol (1981) 0.95
A school outbreak of tuberculosis. Ir Med J (1987) 0.95
Larval foraging behaviour and competition in Drosophila melanogaster. Heredity (Edinb) (1996) 0.95
Characterization of human beta-interferon-binding sites on human cells. J Biol Chem (1985) 0.94
THE NEW ERGOT ALKALOID. Science (1936) 0.94
ApoE polymorphisms and diarrheal outcomes in Brazilian shanty town children. Braz J Med Biol Res (2010) 0.93
Behavioural pleiotropy of the yellow gene in Drosophila melanogaster. Genet Res (1976) 0.93
Genetic analysis of larval feeding behaviour in Drosophila melanogaster. Genet Res (1974) 0.93
Studies on the mode of action of diphtheria toxin. V. Protein metabolism in a guinea pig model simulating chronic diphtheritic toxemia. Infect Immun (1973) 0.93
Absorption of botulinal toxin from the gastrointestinal tract. Rev Infect Dis (1980) 0.93
Implantation metastasis from adenocarcinoma of sigmoid colon into fistula in ano. J R Soc Med (1992) 0.92
Immunohistochemical detection of oxidative DNA damage induced by ischemia-reperfusion insults in gerbil hippocampus in vivo. Brain Res (1999) 0.92